1-Acetyl-4-Piperidinecarboxylic Acid CAS 25503-90-6 Purity ≥98.0% (GC) High Purity

Short Description:

Chemical Name: 1-Acetyl-4-piperidinecarboxylic Acid

Synonyms: 1-Acetylisonipecotic Acid

CAS: 25503-90-6

Appearance: Off-White Powder

Purity: ≥98.0% (HPLC)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply with High Purity and Stable Quality
Chemical Name: 1-Acetyl-4-piperidinecarboxylic Acid
CAS: 25503-90-6
High Quality, Commercial Production

Chemical Properties:

Chemical Name	1-Acetyl-4-Piperidinecarboxylic Acid
Synonyms	1-Acetylpiperidine-4-Carboxylic Acid; 1-Acetylisonipecotic Acid
CAS Number	25503-90-6
CAT Number	RF-PI279
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C8H13NO3
Molecular Weight	171.19
Melting Point	180.0~184.0℃ (lit.)
Solubility	Soluble in Chloroform, Methanol and Water
Shipping Condition	Shipped Under Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Off-White Powder
NMR	Conforms
Loss on Drying	≤0.50%
Purity / Analysis Method	≥98.0% (HPLC)
Single Impurity	≤0.50%
Test Standard	Enterprise Standard
Usage	Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 1-Acetyl-4-piperidinecarboxylic Acid (CAS: 25503-90-6) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API) synthesis.

1-Acetyl-4-piperidinecarboxylic Acid (CAS: 25503-90-6) is a synthetic intermediate utilized in the preparation of CNS depressants.

1-Acetyl-4-piperidinecarboxylic Acid (CAS: 25503-90-6) Application, Reactant for synthesis of:
Triazole derivatives; Antiproliferative agents; CDK inhibitors; CCR5 antagonists for HIV treatment; nhNK1 antagonists; Piperidine derivatives